193 related articles for article (PubMed ID: 24147092)
1. Use of a recombinant vaccinia virus expressing interferon gamma for post-exposure protection against vaccinia and ectromelia viruses.
Holechek SA; Denzler KL; Heck MC; Schriewer J; Buller RM; Legrand FA; Verardi PH; Jones LA; Yilma T; Jacobs BL
PLoS One; 2013; 8(10):e77879. PubMed ID: 24147092
[TBL] [Abstract][Full Text] [Related]
2. Comparable polyfunctionality of ectromelia virus- and vaccinia virus-specific murine T cells despite markedly different in vivo replication and pathogenicity.
Hersperger AR; Siciliano NA; Eisenlohr LC
J Virol; 2012 Jul; 86(13):7298-309. PubMed ID: 22532670
[TBL] [Abstract][Full Text] [Related]
3. Identification of residues in the ectromelia virus gamma interferon-binding protein involved in expanded species specificity.
Nuara AA; Buller RML; Bai H
J Gen Virol; 2007 Jan; 88(Pt 1):51-60. PubMed ID: 17170436
[TBL] [Abstract][Full Text] [Related]
4. Natural Killer Cells and Innate Interferon Gamma Participate in the Host Defense against Respiratory Vaccinia Virus Infection.
Abboud G; Tahiliani V; Desai P; Varkoly K; Driver J; Hutchinson TE; Salek-Ardakani S
J Virol; 2016 Jan; 90(1):129-41. PubMed ID: 26468539
[TBL] [Abstract][Full Text] [Related]
5. A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease.
Israely T; Paran N; Lustig S; Erez N; Politi B; Shafferman A; Melamed S
Virol J; 2012 Jun; 9():119. PubMed ID: 22709563
[TBL] [Abstract][Full Text] [Related]
6. Active vaccination with vaccinia virus A33 protects mice against lethal vaccinia and ectromelia viruses but not against cowpoxvirus; elucidation of the specific adaptive immune response.
Paran N; Lustig S; Zvi A; Erez N; Israely T; Melamed S; Politi B; Ben-Nathan D; Schneider P; Lachmi B; Israeli O; Stein D; Levin R; Olshevsky U
Virol J; 2013 Jul; 10():229. PubMed ID: 23842430
[TBL] [Abstract][Full Text] [Related]
7. Postexposure immunization with modified vaccinia virus Ankara or conventional Lister vaccine provides solid protection in a murine model of human smallpox.
Paran N; Suezer Y; Lustig S; Israely T; Schwantes A; Melamed S; Katz L; Preuss T; Hanschmann KM; Kalinke U; Erez N; Levin R; Velan B; Löwer J; Shafferman A; Sutter G
J Infect Dis; 2009 Jan; 199(1):39-48. PubMed ID: 19012492
[TBL] [Abstract][Full Text] [Related]
8. Gamma interferon-induced interferon regulatory factor 1-dependent antiviral response inhibits vaccinia virus replication in mouse but not human fibroblasts.
Trilling M; Le VT; Zimmermann A; Ludwig H; Pfeffer K; Sutter G; Smith GL; Hengel H
J Virol; 2009 Apr; 83(8):3684-95. PubMed ID: 19211768
[TBL] [Abstract][Full Text] [Related]
9. The unique C termini of orthopoxvirus gamma interferon binding proteins are essential for ligand binding.
Nuara AA; Bai H; Chen N; Buller RM; Walter MR
J Virol; 2006 Nov; 80(21):10675-82. PubMed ID: 16928759
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden.
Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC
PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920
[TBL] [Abstract][Full Text] [Related]
11. Rapid expansion of CD8+ T cells in wild-type and type I interferon receptor-deficient mice correlates with protection after low-dose emergency immunization with modified vaccinia virus Ankara.
Volz A; Langenmayer M; Jany S; Kalinke U; Sutter G
J Virol; 2014 Sep; 88(18):10946-57. PubMed ID: 25008931
[TBL] [Abstract][Full Text] [Related]
12. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T cell help is dispensable for protective CD8+ T cell memory against mousepox virus following vaccinia virus immunization.
Fang M; Remakus S; Roscoe F; Ma X; Sigal LJ
J Virol; 2015 Jan; 89(1):776-83. PubMed ID: 25355885
[TBL] [Abstract][Full Text] [Related]
14. IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.
Verardi PH; Legrand FA; Chan KS; Peng Y; Jones LA; Yilma TD
J Interferon Cytokine Res; 2014 Mar; 34(3):169-78. PubMed ID: 24168450
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses.
Roscoe F; Xu RH; Sigal LJ
J Virol; 2012 Dec; 86(24):13501-7. PubMed ID: 23035222
[TBL] [Abstract][Full Text] [Related]
16. Insufficient Innate Immunity Contributes to the Susceptibility of the Castaneous Mouse to Orthopoxvirus Infection.
Earl PL; Americo JL; Moss B
J Virol; 2017 Oct; 91(19):. PubMed ID: 28747505
[TBL] [Abstract][Full Text] [Related]
17. Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.
Siciliano NA; Hersperger AR; Lacuanan AM; Xu RH; Sidney J; Sette A; Sigal LJ; Eisenlohr LC
J Virol; 2014 Sep; 88(17):10078-91. PubMed ID: 24965457
[TBL] [Abstract][Full Text] [Related]
18. Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
Lustig S; Maik-Rachline G; Paran N; Melamed S; Israely T; Erez N; Orr N; Reuveny S; Ordentlich A; Laub O; Shafferman A; Velan B
Vaccine; 2009 Mar; 27(11):1691-9. PubMed ID: 19195492
[TBL] [Abstract][Full Text] [Related]
19. Selective reconstitution of IFN‑γ gene function in Ncr1+ NK cells is sufficient to control systemic vaccinia virus infection.
Borst K; Flindt S; Blank P; Larsen PK; Chhatbar C; Skerra J; Spanier J; Hirche C; König M; Alanentalo T; Hafner M; Waibler Z; Pfeffer K; Sexl V; Sutter G; Müller W; Graalmann T; Kalinke U
PLoS Pathog; 2020 Feb; 16(2):e1008279. PubMed ID: 32023327
[TBL] [Abstract][Full Text] [Related]
20. Memory CD8⁺ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection.
Remakus S; Rubio D; Lev A; Ma X; Fang M; Xu RH; Sigal LJ
Cell Host Microbe; 2013 May; 13(5):546-557. PubMed ID: 23684306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
